| NCT Number | NCT03801876 |
| Lead Sponsor | NRG Oncology
Collaborators: National Cancer Institute (NCI) |
| Conditions | Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8 +5 more |
| Enrollment | 300 participants |
| Start Date | 2019-06-26 |
| Primary Completion | 2026-12-21 (estimated) |
| Study Completion | 2031-12-21 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-25 |